INTRODUCTION
Eosinophilia is a frequent cause of consultation in our speciality. A number of allergic, infectious, neoplastic and idiopathic diseases are associated to eosinophilia. We report the case of a woman who was referred because non productive cough, dyspnea, and rash papular for several weeks. Eosinophilia had been detected in the analyses performed (23 %; 2.162 cells/ml).
The Churg-Strauss syndrome is a rare disease, ocurring in an estimated two to four patients per million patient-year1,2. This syndrome has been divided into 3 distinct phases, which may or may not be sequential. The prodromal phase is characterized by asthma with or without allergic rhinitis. The second phase is marked by a peripheral blood eosinophilia and eosinophilic tissue infiltration producing a picture similar to Loeffler syndrome, chronic eosinophilic pneumonia, or eosinophilic gastroenteritis. The third, vasculitic phase may involve any organ: heart, lung, central nervous system, kidney, lymph nodes, muscle, and skin. Skin involvement occurs in more than two-thirds of patients3.
CASE REPORT
A 47-year-old woman presented dyspnea and non productive cough for tree months. Her history revealed that she had perennial rhinitis, poliposis and sinusitis. Two weeks later, she developed a pruritic rash papular involving her back, chest and lower extremities. She had no history of other lung diseases, fever tobacco use, allergies or a change in her home. The patient's symptoms improved during treatment with bronchodilatadors and inhaled corticosteroids, but the dyspnea recurred when the dose was stopped after four weeks. The patient recalled that the had similar skin lesion on her legs two years earlier, but they had resolved when she was treated with prednisone.
The triad of asthma, sinus disease, and eosinophilia is suggestive of the Churg-Strauss syndrome, but other possible diagnoses include allergic bronchopulmonary aspergillosis, cancer, helminthic infection, eosinophilic pneumonia and hypersensitivity pneumonitis.
METHODS AND RESULTS
Skin prick-test and IgE especific with a battery of common inhalant allergens and foods were negative. Another causes of eosinophilia is an infestation by parasitic helminths, but studies of parasites in faeces and serologic test for antibodies against Strongyloides, Echinococcus, Trichinella, etc. were negative.
Laboratory tests showed a hemoglobin level of 14 g/dL, a hematocrit of 42 %, leukocytes of 9400/mm3, eosinophils of 2162/mm3 (23 %), platelets of 228,000/mm3, an erythrocyte sedimentation rate of 85 mm/h, and immunoglobulin E (IgE) elevated to 338 U/mL Test for antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibody were negative. Urinalysis, complement, and antinuclear antibody tests were normal or negative. Physical examination demonstrated several erythematous plaques, with ill-defined borders on the back, chest and lower extremities.
The results of pulmonary-function test were consistent with the presence of severe, partially reversible airflow obstruction. X-rays of the paranasal sinuses revealed opacification and chest roentgenogram showed a micronodular infiltrate in the right apex and inferior lobe. A thoraco CT scan revealed several small lymph nodes, and diffuse infiltrates.
The evaluation was negative for allergic bronchopulmonary aspergillosis: skin and serologic test for aspergillus-specific antibodies were negative and chest CT did not show central bronchiectasis.
A review of outpatient records revealed that the proportion of eosinophils on a complete blood count had been 10 percent four years earlier (1850/mm3) and 20 percent (2027/mm3) on a more recent count. Although eosinophilia may accompany asthma, the levels rarely exceed 800 per cubic millimeter even in severe cases. In addition, the patient,s erytrocyte sedimentation rate is markedly elevated, a finding not seen in asthma.
Because the diagnosis remained uncertain, a transbronquial biopsy and biopsy of skin lesion were performed. The transbronchial biopsy revealed diffuse eosinophilic infiltrates and a biopsy of the skin demonstrated an infiltration in the dermis with a predominance of eosinophils infiltrating the vascular walls. There were no granulomas.
Treatment with 60 mg of prednisone per day was begun, and the dose was tapered over a period of several months to 5 mg per day. She showed a good response to oral corticosteroids, with total remission of symptoms and normalization of the eosinophil count, IgE levels and pulmonary-function test.
DISCUSSION
The Churg-Strauss syndrome is the major vasculitis associated with eosinophilia. In 1990, the American College of Rheumatology developed criteria for epidemiologic and therapeutic studies. These criteria are asthma, eosinophilia greater than 10 % on a differential white blood cell count, mono- or polyneuropathy, nonfixed pulmonary infiltrates, paranasal sinus abnormalities, and biopsy containing a blood vessel with extravascular granulomas. The presence of 4 of the 6 criteria yielded a sensitivity of 85 % and a specificity of 99.7 %4.
This syndrome is distinguished from other systemic vasculitis by the presence of asthma. Involvement of the peripheral nerves, gastrointestinal tract and skin is common. Perinuclear ANCA, present in most patients, should be considered as a major diadnostic criterion but have not proven useful for follow-up purposes5. The etiology of Churg-Strauss syndrome remains unclear; however, the presence of asthma, eosinophilia, and increased immunoglobulin E (IgE) suggest an allergic process.
We present a 47-year-old woman, with difficult-to-control asthma, rhinosinusitis and rash papular, wich were the prodomal phase of Churg-Strauss syndrome. The prominent eosinophilic infiltrates of the skin and lung confirmed the presence of a systemic eosinophilic syndrome.
A rapid improvement of clinical manifestations, analytical parameters, and radiological images coincided with the administration of systemic corticosteroids. In most patients with this syndrome, the eosinophilia and symptoms respond quickly to corticosteroid therapy, but residual asthma may require continuation of low-dose prednisone, and some may benefit from interferon alfa6,7. This syndrome is diagnosed in some patients who are receiving leukotriene antagonist but whether this drug cause the syndrome remains uncertain8,9.
Because a delay in the diagnosis and treatment of the syndrome increases the risk of death from vasculitis complications involving the heart (cardiac involvement is the most common cause of death due to pericarditis or ischemia in the vasculitic phase), gastrointestinal tract, or other organs10, their presence must be considered when a patient's symptoms and signs are atypical of asthma alone. Therefore, we think that the allergologist should be aware of Churg-Strauss syndrome as a cause of eosinophilia.
